For citations:
Volkonskiy M.V., Akopyan A.A., Zhelezkova T.A., Zhikhorev R.S., Krasnorutskaya E.P., Abidova N.R., Makarkina T.A., Skorina M.O., Filippova V.M., Luev I.A., Vasilyeva Yu.V., Malina G.D., Veshkina L.P., Nersesyan B.L. Efficacy and safety of combination therapy with lenvatinib and pembrolizumab in elderly patients with advanced endometrial cancer. Tumors of female reproductive system. 2025;21(1):116-122. (In Russ.) https://doi.org/10.17650/1994-4098-2025-21-1-116-122
Email this article 